NQO1 polymorphisms are associated with an increased risk of some neurological disorders, such as MS and AD, likely due to structural and functional alterations of NQO1 and disruption in the cellular antioxidant defence [58]. This evidence concerns the gene NQO1 and myeloid sarcoma.